Questions, Feedback & Help
Send us an email and we'll get back to you ASAP. Or you can read our Frequently Asked Questions.

WormBase Tree Display for WBProcess: WBbiopr:00000014

expand all nodes | collapse all nodes | view schema

Name Class

WBbiopr:00000014Public_nameProgrammed cell death
SummaryProgrammed cell death (PCD), or apoptosis, is an integral component of C. elegans development. During development, 131 cells are fated to die by apoptosis. PCD is easily observed with Nomarski optics in the C. elegans embryo; the nucleus of the apoptotic cell becomes refractile, resembling a flat button, making C. elegans an easy model for following apoptotic cell death. PCD in C. elegans can be divided into three main phases (with participating genes): specification of which cells should live or die (ces-1, ces-2, in general); activation of the cell killing machinery (egl-1, ced-9, ced-4 and ced-3); and an execution phase where the dying cell is dismantled and removed through phagocytosis (ced-1,-2,-5,-6,-7,-10 and-12), which occurs in concert with apoptotic DNA degradation (cps-6, nuc-1). Molecular and biochemical studies in C. elegans revealed programmed cell death mechanisms conserved in humans. The regulatory pathway that controls cell death is composed of conserved cell death activators and inhibitors: EGL-1 and BH3-domain-only proteins, CED-9 and Bcl-2, CED-4 and Apaf-1, and CED-3 and caspases, in nematodes and mammals, respectively. Further the degradation of chromosomal DNA involves a mitochondrial proapoptotic endonuclease: endonuclease G (EndoG), and AIF in mammals and their orthologs CPS-6 and WAH-1 in worms.
Other_nameApoptosis
PCD
Related_topicSpecialisation_ofWBbiopr:00000013
Generalisation_ofWBbiopr:00000015
WBbiopr:00000066
Involved_entityGene (48)
Interaction (81)
Anatomy_termWBbt:0005784Paper_evidenceWBPaper00004574
Associated_withPhenotype (35)
GO_termGO:0012501
GO:0006309
GO:0006915
GO:0043652
Picture (21)
PathwayDB_infoDatabaseWikiPathwaysPathwayWP2829
WP367
WP2226
Remarkhttp:
Reference (562)